Biological warfare (BW) threat assessments identify and prioritize BW threats to civilian and military populations. In an ideal world, they provide policymakers with clear and compelling guidance to prioritize biodefense research, development, testing, evaluation, and acquisition of countermeasures. Unfortunately, the biodefense community does not exist in an ideal world. National security professionals responsible for crafting BW threat assessments often are challenged by factors that limit the clarity and/or timeliness of those assessments. Moreover, the potential for life science advances to enhance threats enabled by state programs and the possibility that non-state actors may pursue crude but effective BW methodologies will drastically expand the scope of the perceived threat. Appropriate investment of federal biodefense funds will require some mechanism for validating and prioritizing present and future threats. Ideally, such a mechanism will incorporate empirical data targeted to elucidate actual hazards. In this regard, the Department of Homeland Security's creation of a Biological Threat Characterization Program for the technical validation of threat agents will be a valuable addition to the nation's overall biodefense strategy. This article articulates the need for a coordinated national biological threat characterization program, discusses some of the principal challenges associated with such research, and suggests a few options for their resolution.
[1]
A. Ramsay,et al.
Expression of Mouse Interleukin-4 by a Recombinant Ectromelia Virus Suppresses Cytolytic Lymphocyte Responses and Overcomes Genetic Resistance to Mousepox
,
2001,
Journal of Virology.
[2]
B. Graham,et al.
Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine.
,
2001,
The Journal of general virology.
[3]
M. Leitenberg,et al.
Biological Weapons in the Twentieth Century: A Review and Analysis
,
2001,
Critical reviews in microbiology.
[4]
M. Leitenberg.
Distinguishing Offensive from Defensive Biological Weapons Research
,
2003,
Critical reviews in microbiology.
[5]
Ari Schuler,et al.
Billions for biodefense: federal agency biodefense budgeting, FY2005-FY2006.
,
2005,
Biosecurity and bioterrorism : biodefense strategy, practice, and science.
[6]
M. Norazmi.
Possible mechanism for the enhanced lethality of an interleukin-4-expressing mousepox virus.
,
2001,
Journal of medical microbiology.
[7]
M. Rolph,et al.
Interleukin-4-mediated downregulation of cytotoxic T lymphocyte activity is associated with reduced proliferation of antigen-specific CD8+ T cells.
,
2003,
Microbes and infection.